NCT00774189View on ClinicalTrials.gov

Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

clarithromycin 250 mg tablets

Trial Locations (1)

122001

Ranbaxy Research Laboratories, Gurgaon

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00774189 - Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter